Cargando…

Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia

Ceruloplasmin (Cp) is a ferroxidase that also plays a role in iron efflux from cells. It can thus help to regulate cellular iron homeostasis. In the CNS, Cp is expressed as a membrane-anchored form by astrocytes. Here, we assessed the role of Cp in permanent middle cerebral artery occlusion (pMCAO)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Fari, Zarruk, Juan G., Lößlein, Lena, David, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331473/
https://www.ncbi.nlm.nih.gov/pubmed/30670944
http://dx.doi.org/10.3389/fnins.2018.00988
_version_ 1783387138854748160
author Ryan, Fari
Zarruk, Juan G.
Lößlein, Lena
David, Samuel
author_facet Ryan, Fari
Zarruk, Juan G.
Lößlein, Lena
David, Samuel
author_sort Ryan, Fari
collection PubMed
description Ceruloplasmin (Cp) is a ferroxidase that also plays a role in iron efflux from cells. It can thus help to regulate cellular iron homeostasis. In the CNS, Cp is expressed as a membrane-anchored form by astrocytes. Here, we assessed the role of Cp in permanent middle cerebral artery occlusion (pMCAO) comparing wildtype and Cp null mice. Our studies show that the lesion size is larger and functional recovery impaired in Cp null mice compared to wildtype mice. Expression of Cp increased ninefold at 72 h after pMCAO and remained elevated about twofold at day 14. We also assessed changes in mRNA and protein expression of molecules involved in iron homeostasis. As expected there was a reduction in ferroportin in Cp null mice at 72 h. There was also a remarkable increase in DMT1 protein in both genotypes at 72 h, being much higher in wildtype mice (19.5-fold), that then remained elevated about twofold at 14 days. No difference was seen in transferrin receptor 1 (TfR1) expression, except a small reduction in wildtype mice at 72 h, suggesting that the increase in DMT1 may underlie iron uptake independent of TfR1-endosomal uptake. There was also an increase of ferritin light chain in both genotypes. Iron histochemistry showed increased iron accumulation after pMCAO, initially along the lesion border and later throughout the lesion. Immunofluorescence labeling for ferritin (a surrogate marker for iron) and GFAP or CD11b showed increased ferritin in GFAP+ astrocytes along the lesion border in Cp null mice, while CD11b+ macrophages expressed ferritin equally in both genotypes. Increased lipid peroxidation assessed by 4HNE staining was increased threefold in Cp null mice at 72 h after pMCAO; and 3-nitrotyrosine labeling showed a similar trend. Three key pro-inflammatory cytokines (IL-1β, TNFα, and IL-6) were markedly increased at 24 h after pMCAO equally in both genotypes, and remained elevated at lower levels later, indicating that the lack of Cp does not alter key inflammatory cytokine expression after pMCAO. These data indicate that Cp expression is rapidly upregulated after pMCAO, and loss of Cp results in dysregulation of iron homeostasis, increased oxidative damage, greater lesion size and impaired recovery of function.
format Online
Article
Text
id pubmed-6331473
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63314732019-01-22 Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia Ryan, Fari Zarruk, Juan G. Lößlein, Lena David, Samuel Front Neurosci Neuroscience Ceruloplasmin (Cp) is a ferroxidase that also plays a role in iron efflux from cells. It can thus help to regulate cellular iron homeostasis. In the CNS, Cp is expressed as a membrane-anchored form by astrocytes. Here, we assessed the role of Cp in permanent middle cerebral artery occlusion (pMCAO) comparing wildtype and Cp null mice. Our studies show that the lesion size is larger and functional recovery impaired in Cp null mice compared to wildtype mice. Expression of Cp increased ninefold at 72 h after pMCAO and remained elevated about twofold at day 14. We also assessed changes in mRNA and protein expression of molecules involved in iron homeostasis. As expected there was a reduction in ferroportin in Cp null mice at 72 h. There was also a remarkable increase in DMT1 protein in both genotypes at 72 h, being much higher in wildtype mice (19.5-fold), that then remained elevated about twofold at 14 days. No difference was seen in transferrin receptor 1 (TfR1) expression, except a small reduction in wildtype mice at 72 h, suggesting that the increase in DMT1 may underlie iron uptake independent of TfR1-endosomal uptake. There was also an increase of ferritin light chain in both genotypes. Iron histochemistry showed increased iron accumulation after pMCAO, initially along the lesion border and later throughout the lesion. Immunofluorescence labeling for ferritin (a surrogate marker for iron) and GFAP or CD11b showed increased ferritin in GFAP+ astrocytes along the lesion border in Cp null mice, while CD11b+ macrophages expressed ferritin equally in both genotypes. Increased lipid peroxidation assessed by 4HNE staining was increased threefold in Cp null mice at 72 h after pMCAO; and 3-nitrotyrosine labeling showed a similar trend. Three key pro-inflammatory cytokines (IL-1β, TNFα, and IL-6) were markedly increased at 24 h after pMCAO equally in both genotypes, and remained elevated at lower levels later, indicating that the lack of Cp does not alter key inflammatory cytokine expression after pMCAO. These data indicate that Cp expression is rapidly upregulated after pMCAO, and loss of Cp results in dysregulation of iron homeostasis, increased oxidative damage, greater lesion size and impaired recovery of function. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331473/ /pubmed/30670944 http://dx.doi.org/10.3389/fnins.2018.00988 Text en Copyright © 2019 Ryan, Zarruk, Lößlein and David. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Ryan, Fari
Zarruk, Juan G.
Lößlein, Lena
David, Samuel
Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
title Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
title_full Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
title_fullStr Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
title_full_unstemmed Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
title_short Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia
title_sort ceruloplasmin plays a neuroprotective role in cerebral ischemia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331473/
https://www.ncbi.nlm.nih.gov/pubmed/30670944
http://dx.doi.org/10.3389/fnins.2018.00988
work_keys_str_mv AT ryanfari ceruloplasminplaysaneuroprotectiveroleincerebralischemia
AT zarrukjuang ceruloplasminplaysaneuroprotectiveroleincerebralischemia
AT loßleinlena ceruloplasminplaysaneuroprotectiveroleincerebralischemia
AT davidsamuel ceruloplasminplaysaneuroprotectiveroleincerebralischemia